Skip to content
FIND A HEALTH VALLEY ACTOR
Plair Team

Plair brings its Rapid-C+ on the market

04.09.2024
Share this article

Rapid-C+, an advanced real-time air microbial detector that sets new standards in environmental monitoring, is now on the market. The device was designed by Plair, a Geneva-based startup.

 

 

Rapid-C+ uses patented biofluorescent particle counting technology to detect and identify viable contaminants in real time. Its state-of-the-art features include laser-based light scattering and fluorescence spectroscopy, allowing it to sensitively detect living microorganisms while distinguishing them from non-biological materials like plastics or disinfectants.

The device integrates real-time viable and total particle counting with traditional air sampling methods into one device. This innovation enhances contamination control, particularly in industries like pharmaceuticals, by improving safety and efficiency in monitoring and responding to contamination risks. It supports the recent EU GMP Annex 1 guidelines for sterile medicinal products.

Rapid-C+ was developed with input from customers in cleanliness-critical industries and is designed to improve process understanding and root-cause investigations. Plair has also established a bioaerosol testing facility to validate and compare various microbiological testing methods.

The Swiss State Secretariat for Education, Research and Innovation has supported its development with a CHF 2.7 million grant, enabling commercialization for the aseptic processing market. Plair is also a FONGIT alumni and got a CHF 300’000 grant to develop its product.

 

 

Source : press release
📸 The Plair Team. © Plair